Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum
Recruiting
- Conditions
- Cancers of different originC30-C39Malignant neoplasms of respiratory and intrathoracic organs
- Registration Number
- DRKS00006297
- Lead Sponsor
- Klinik für Radio-OnkologieUniversitätsSpital Zürich
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
NSCLC treated with stereotactic body radiotherapy or nomally fractionated radiotherapy. In addition, patients with cancers of different origin and treated with SBRT may also be included for biomarker analysis.
Exclusion Criteria
Postoperative radiotherapy. Pregnant or lactating women.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Explorative biomarker analysis in blood serum, plasma and whole blood before, during and after radiotherapy
- Secondary Outcome Measures
Name Time Method